Literature DB >> 19353591

Hyposmia and executive dysfunction as predictors of future Parkinson's disease: a prospective study.

Mirthe M Ponsen1, Diederick Stoffers, Jos W R Twisk, Erik Ch Wolters, Henk W Berendse.   

Abstract

Olfactory deficits and executive dysfunction are early and common symptoms in Parkinson's disease (PD). Previous studies have shown that hyposmia can be a first sign of PD. The aim of the present study was to determine which of three olfactory tests and two selected tests of executive function would be the best predictor of future PD over a 5 year period. In a cohort of 361 nonparkinsonian, nondemented first-degree relatives of PD patients, in whom alternative causes of olfactory dysfunction were excluded, we measured baseline performance on three olfactory and two executive function tasks. Five years from baseline, clinical neurological evaluation and/or a screening questionnaire, sensitive to the presence of Parkinsonism, were used to detect individuals developing clinical PD. Our results show that in first degree relatives of PD patients worse performance on each of three olfactory processing tasks was associated with an increased risk of developing PD within 5 years, whereas performance on selected tests of executive dysfunction was not associated with an increased risk of developing PD. Interestingly, impaired odor discrimination was the best predictor for future PD. (c) 2009 Movement Disorder Society.

Entities:  

Mesh:

Year:  2009        PMID: 19353591     DOI: 10.1002/mds.22534

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  37 in total

1.  Olfactory functions at the intersection between environmental exposure to manganese and Parkinsonism.

Authors:  Silvia Zoni; Giulia Bonetti; Roberto Lucchini
Journal:  J Trace Elem Med Biol       Date:  2012-06-02       Impact factor: 3.849

2.  Olfactory bulb volume and depth of olfactory sulcus in patients with idiopathic olfactory loss.

Authors:  Ph Rombaux; H Potier; E Markessis; T Duprez; T Hummel
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-03-19       Impact factor: 2.503

3.  Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings.

Authors:  Lama M Chahine; Daniel Weintraub; Keith A Hawkins; Andrew Siderowf; Shirley Eberly; David Oakes; John Seibyl; Matthew B Stern; Kenneth Marek; Danna Jennings
Journal:  Mov Disord       Date:  2015-08-21       Impact factor: 10.338

4.  Cranial nerve I: olfaction.

Authors:  Richard D Sanders; Paulette Marie Gillig
Journal:  Psychiatry (Edgmont)       Date:  2009-07

5.  Clinical trials of disease-modifying therapies for neurodegenerative diseases: the challenges and the future.

Authors:  Anthony E Lang
Journal:  Nat Med       Date:  2010-09-21       Impact factor: 53.440

6.  Specific intranasal and central trigeminal electrophysiological responses in Parkinson's disease.

Authors:  Cécilia Tremblay; Rosa Emrich; Annachiara Cavazzana; Lisa Klingelhoefer; Moritz D Brandt; Thomas Hummel; Antje Haehner; Johannes Frasnelli
Journal:  J Neurol       Date:  2019-08-26       Impact factor: 4.849

7.  Cognition and the course of prodromal Parkinson's disease.

Authors:  Daniel Weintraub; Lana M Chahine; Keith A Hawkins; Andrew Siderowf; Shirley Eberly; David Oakes; John Seibyl; Matthew B Stern; Kenneth Marek; Danna Jennings
Journal:  Mov Disord       Date:  2017-10-24       Impact factor: 10.338

Review 8.  Can Biomarkers Help the Early Diagnosis of Parkinson's Disease?

Authors:  Weidong Le; Jie Dong; Song Li; Amos D Korczyn
Journal:  Neurosci Bull       Date:  2017-09-02       Impact factor: 5.203

Review 9.  From manganism to manganese-induced parkinsonism: a conceptual model based on the evolution of exposure.

Authors:  Roberto G Lucchini; Christopher J Martin; Brent C Doney
Journal:  Neuromolecular Med       Date:  2009-12-10       Impact factor: 3.843

Review 10.  Olfactory loss as a supporting feature in the diagnosis of Parkinson's disease: a pragmatic approach.

Authors:  Katie Hoyles; Jagdish C Sharma
Journal:  J Neurol       Date:  2013-02-03       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.